Melatonin for the treatment of irritable bowel syndrome

World Journal of Gastroenterology

Volumn 20, Issue 10, 2014, Pages 2492-2498

  Siah, Kewin Tien Ho ^a,b   Wong, Reuben Kong Min ^a,b   Ho, Khek Yu ^a,b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Analgesia; Irritable bowel syndrome; Melatonin; Pain; Sleep

Indexed keywords

MELATONIN; PLACEBO; GASTROINTESTINAL AGENT;

ABDOMINAL PAIN; ARTICLE; BEDTIME DOSAGE; CLINICAL FEATURE; DISEASE SEVERITY; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HEADACHE; HUMAN; INTESTINE TRANSIT TIME; IRRITABLE COLON; MORNING DOSAGE; NIGHTMARE; NONHUMAN; QUALITY OF LIFE; RASH; REM SLEEP; ADVERSE EFFECTS; ANIMAL; COMPLICATION; DIET SUPPLEMENTATION; DRUG EFFECTS; INTESTINE; IRRITABLE BOWEL SYNDROME; METABOLISM; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ABDOMINAL PAIN; ANIMALS; DIETARY SUPPLEMENTS; GASTROINTESTINAL AGENTS; HUMANS; INTESTINES; IRRITABLE BOWEL SYNDROME; MELATONIN; TREATMENT OUTCOME;

EID: 84896805569     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i10.2492     Document Type: Article

References (73)

1. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003; 17: 643-650 [PMID: 12641512 DOI: 10.1046/ j.1365-2036.2003.01456.x]
2. Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991; 101: 927-934 [PMID: 1889716]
3. Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Quigley EM. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009; 104 Suppl 1: S1-35 [PMID: 19521341 DOI: 10.1038/ajg.2008.122]
4. Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol 1998; 93: 1816-1822 [PMID: 9772037 DOI: 10.1111/ j.1572-0241.1998.00526.x]
5. Gwee KA, Wee S, Wong ML, Png DJ. The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community. Am J Gastroenterol 2004; 99: 924-931 [PMID: 15128362 DOI: 10.1111/ j.1572-0241.2004.04161.x]
6. Wong RK, Drossman DA, Weinland SR, Morris CB, Leserman J, Hu Y, Kelapure R, Bangdiwala SI. Partner burden in irritable bowel syndrome. Clin Gastroenterol Hepatol 2013; 11: 151-155 [PMID: 22858730 DOI: 10.1016/j.cgh.2012.07.019]
7. Hammerle CW, Surawicz CM. Updates on treatment of irritable bowel syndrome. World J Gastroenterol 2008; 14: 2639-2649 [PMID: 18461649 DOI: 10.3748/wjg.14.2639]
8. Srinivasan V, Pandi-Perumal SR, Trahkt I, Spence DW, Poeggeler B, Hardeland R, Cardinali DP. Melatonin and melatonergic drugs on sleep: possible mechanisms of action. Int J Neurosci 2009; 119: 821-846 [PMID: 19326288 DOI: 10.1080/00207450802328607]
9. Fornaro M, Prestia D, Colicchio S, Perugi G. A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation. Curr Neuropharmacol 2010; 8: 287-304 [PMID: 21358978 DOI: 10.2174/157015910792246227]
10. Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991; 12: 151-180 [PMID: 1649044 DOI: 10.1210/edrv-12-2-151]
11. Bubenik GA, Brown GM, Grota LJ. Immunohistological localization of melatonin in the rat digestive system. Experientia 1977; 33: 662-663 [PMID: 324794 DOI: 10.1007/BF01946561]
12. Rice J, Mayor J, Tucker HA, Bielski RJ. Effect of light therapy on salivary melatonin in seasonal affective disorder. Psychiatry Res 1995; 56: 221-228 [PMID: 7568544 DOI: 10.1016/0165-1781(95)02610-9]
13. Bubenik GA, Pang SF, Hacker RR, Smith PS. Melatonin concentrations in serum and tissues of porcine gastrointestinal tract and their relationship to the intake and passage of food. J Pineal Res 1996; 21: 251-256 [PMID: 8989725 DOI: 10.1111/ j.1600-079X.1996.tb00294.x]
14. Drago F, Macauda S, Salehi S. Small doses of melatonin increase intestinal motility in rats. Dig Dis Sci 2002; 47: 1969-1974 [PMID: 12353839]
15. Storr M, Koppitz P, Sibaev A, Saur D, Kurjak M, Franck H, Schusdziarra V, Allescher HD. Melatonin reduces nonadrenergic, non-cholinergic relaxant neurotransmission by inhibition of nitric oxide synthase activity in the gastrointestinal tract of rodents in vitro. J Pineal Res 2002; 33: 101-108 [PMID: 12153444 DOI: 10.1034/j.1600-079X.2002.02909.x]
16. Raghavendra V, Singh V, Kulkarni SK, Agrewala JN. Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists. Mol Cell Biochem 2001; 221: 57-62 [PMID: 11506187]
17. Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ. A review of the multiple actions of melatonin on the immune system. Endocrine 2005; 27: 189-200 [PMID: 16217132]
18. Cuzzocrea S, Costantino G, Mazzon E, Caputi AP. Regulation of prostaglandin production in carrageenan-induced pleurisy by melatonin. J Pineal Res 1999; 27: 9-14 [PMID: 10451019 DOI: 10.1111/j.1600-079X.1999.tb00591.x]
19. Crespo E, Macías M, Pozo D, Escames G, Martín M, Vives F, Guerrero JM, Acuña-Castroviejo D. Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats. FASEB J 1999; 13: 1537-1546 [PMID: 10463945]
20. Deng WG, Tang ST, Tseng HP, Wu KK. Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood 2006; 108: 518-524 [PMID: 16609073 DOI: 10.1182/blood-2005-09-3691]
21. Roberts-Thomson IC, Knight RE, Kennaway DJ, Pannall PR. Circadian rhythms in patients with abdominal pain syndromes. Aust N Z J Med 1988; 18: 569-574 [PMID: 3196244 DOI: 10.1111/j.1445-5994.1988.tb00126.x]
22. Brown GM. Melatonin in psychiatric and sleep disorders. CNS Drug 1995; 3: 209-226 [DOI: 10.2165/00023210-19950303 0-00006]
23. Bubenik GA, Blask DE, Brown GM, Maestroni GJ, Pang SF, Reiter RJ, Viswanathan M, Zisapel N. Prospects of the clinical utilization of melatonin. Biol Signals Recept 1998; 7: 195-219 [PMID: 9730580 DOI: 10.1159/000014545]
24. Nordlund JJ, Lerner AB. The effects of oral melatonin on skin color and on the release of pituitary hormones. J Clin Endocrinol Metab 1977; 45: 768-774 [PMID: 914981 DOI: 10.1210/jcem-45-4-768]
25. Papavasiliou PS, Cotzias GC, Düby SE, Steck AJ, Bell M, Lawrence WH. Melatonin and parkinsonism. JAMA 1972; 221: 88-89 [PMID: 5067774 DOI: 10.1001/jama.1972.03200140 072031]
26. Lu WZ, Gwee KA, Moochhalla S, Ho KY. Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study. Aliment Pharmacol Ther 2005; 22: 927-934 [PMID: 16268966 DOI: 10.1111/j.1365-2036.2005.02673.x]
27. Saha L, Malhotra S, Rana S, Bhasin D, Pandhi P. A preliminary study of melatonin in irritable bowel syndrome. J Clin Gastroenterol 2007; 41: 29-32 [PMID: 17198061 DOI: 10.1097/ MCG.0b013e31802df84c]
28. Fass R, Fullerton S, Tung S, Mayer EA. Sleep disturbances in clinic patients with functional bowel disorders. Am J Gastroenterol 2000; 95: 1195-2000 [PMID: 10811327 DOI: 10.1111/ j.1572-0241.2000.02009.x]
29. Corney RH, Stanton R. Physical symptom severity, psychological and social dysfunction in a series of outpatients with irritable bowel syndrome. J Psychosom Res 1990; 34: 483-491 [PMID: 2231481 DOI: 10.1016/0022-3999(90)90022-V]
30. Nyhlin H, Ford MJ, Eastwood J, Smith JH, Nicol EF, Elton RA, Eastwood MA. Non-alimentary aspects of the irritable bowel syndrome. J Psychosom Res 1993; 37: 155-162 [PMID: 8385215 DOI: 10.1016/0022-3999(93)90082-Q]
31. Orr WC. Sleep and functional bowel disorders: can bad bowels cause bad dreams? Am J Gastroenterol 2000; 95: 1118-1121 [PMID: 10811314 DOI: 10.1111/j.1572-0241.2000.01996.x]
32. Goldsmith G, Levin JS. Effect of sleep quality on symptoms of irritable bowel syndrome. Dig Dis Sci 1993; 38: 1809-1814 [PMID: 8404401 DOI: 10.1007/BF01296103]
33. Jarrett M, Heitkemper M, Cain KC, Burr RL, Hertig V. Sleep disturbance influences gastrointestinal symptoms in women with irritable bowel syndrome. Dig Dis Sci 2000; 45: 952-959 [PMID: 10795760]
34. Heitkemper M, Jarrett M, Burr R, Cain KC, Landis C, Lentz M, Poppe A. Subjective and objective sleep indices in women with irritable bowel syndrome. Neurogastroenterol Motil 2005; 17: 523-530 [PMID: 16078941 DOI: 10.1111/ j.1365-2982.2005.00700.x]
35. Cremonini F, Camilleri M, Zinsmeister AR, Herrick LM, Beebe T, Talley NJ. Sleep disturbances are linked to both upper and lower gastrointestinal symptoms in the general population. Neurogastroenterol Motil 2009; 21: 128-135 [PMID: 18823289 DOI: 10.1111/j.1365-2982.2008.01181.x]
36. Miwa H. Life style in persons with functional gastrointestinal disorders--large-scale internet survey of lifestyle in Japan. Neurogastroenterol Motil 2012; 24: 464-471, e217 [PMID: 22292849]
37. Kumar D, Thompson PD, Wingate DL, Vesselinova-Jenkins CK, Libby G. Abnormal REM sleep in the irritable bowel syndrome. Gastroenterology 1992; 103: 12-17 [PMID: 1612320]
38. Orr WC, Crowell MD, Lin B, Harnish MJ, Chen JD. Sleep and gastric function in irritable bowel syndrome: derailing the brain-gut axis. Gut 1997; 41: 390-393 [PMID: 9378397 DOI: 10.1136/gut.41.3.390]
39. Bellini M, Gemignani A, Gambaccini D, Toti S, Menicucci D, Stasi C, Costa F, Mumolo MG, Ricchiuti A, Bedini R, de Bortoli N, Marchi S. Evaluation of latent links between irritable bowel syndrome and sleep quality. World J Gastroenterol 2011; 17: 5089-5096 [PMID: 22171143 DOI: 10.3748/wjg.v17.i46.5089]
40. Chen CL, Liu TT, Yi CH, Orr WC. Evidence for altered anorectal function in irritable bowel syndrome patients with sleep disturbance. Digestion 2011; 84: 247-251 [PMID: 21952561 DOI: 10.1159/000330847]
41. Lewy AJ, Ahmed S, Jackson JM, Sack RL. Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol Int 1992; 9: 380-392 [PMID: 1394610 DOI: 10.3109/07420529209064550]
42. Dollins AB, Lynch HJ, Wurtman RJ, Deng MH, Kischka KU, Gleason RE, Lieberman HR. Effect of pharmacological daytime doses of melatonin on human mood and performance. Psychopharmacology (Berl) 1993; 112: 490-496 [PMID: 7871062 DOI: 10.1007/BF02244899]
43. Reiter RJ. Melatonin: clinical relevance. Best Pract Res Clin Endocrinol Metab 2003; 17: 273-285 [PMID: 12787552 DOI: 10.1016/S1521-690X(03)00016-2]
44. Kennaway DJ, Wright H. Melatonin and circadian rhythms. Curr Top Med Chem 2002; 2: 199-209 [PMID: 11899101 DOI: 10.2174/1568026023394380]
45. Gilbert SS, van den Heuvel CJ, Dawson D. Daytime melatonin and temazepam in young adult humans: equivalent effects on sleep latency and body temperatures. J Physiol 1999; 514 (Pt 3): 905-914 [PMID: 9882760 DOI: 10.1111/j.1469-7793.1999.905ad.x]
46. Cajochen C, Kräuchi K, Wirz-Justice A. Role of melatonin in the regulation of human circadian rhythms and sleep. J Neuroendocrinol 2003; 15: 432-437 [PMID: 12622846 DOI: 10.1046/ j.1365-2826.2003.00989.x]
47. Claustrat B, Brun J, David M, Sassolas G, Chazot G. Melatonin and jet lag: confirmatory result using a simplified protocol. Biol Psychiatry 1992; 32: 705-711 [PMID: 1457626 DOI: 10.1016/0006-3223(92)90300-O]
48. Kunz D, Mahlberg R, Müller C, Tilmann A, Bes F. Melatonin in patients with reduced REM sleep duration: two randomized controlled trials. J Clin Endocrinol Metab 2004; 89: 128-134 [PMID: 14715839 DOI: 10.1210/jc.2002-021057]
49. Hughes RJ, Badia P. Sleep-promoting and hypothermic effects of daytime melatonin administration in humans. Sleep 1997; 20: 124-131 [PMID: 9143072]
50. Surdea-Blaga T, Bǎban A, Dumitrascu DL. Psychosocial determinants of irritable bowel syndrome. World J Gastroenterol 2012; 18: 616-626 [PMID: 22363132 DOI: 10.3748/wjg.v18. i7.616]
51. Sandyk R, Pardeshi R. Mood-dependent fluctuations in the severity of tardive dyskinesia and psoriasis vulgaris in a patient with schizoaffective disorder: possible role of melatonin. Int J Neurosci 1990; 50: 215-221 [PMID: 2265899 DOI: 10.3109/00207459008987174]
52. Drossman DA, Chang L. Psychosocial factors in the care of patients with GI disorders. In: Yamada T, edition. Textbook of gastroenterology. Philadelphia: Lippincott-Raven, 2003: 636-654
53. Whitehead WE, Engel BT, Schuster MM. Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients. Dig Dis Sci 1980; 25: 404-413 [PMID: 7379673 DOI: 10.1007/BF01395503]
54. Gomborone J, Dewsnap P, Libby G, Farthing M. Abnormal illness attitudes in patients with irritable bowel syndrome. J Psychosom Res 1995; 39: 227-230 [PMID: 7595881 DOI: 10.1016 /0022-3999(94)00126-P]
55. [Georgiǐ Iosifovich Burchinskiǐ (on his 70th birthday)]. Klin Med (Mosk) 1978; 56: 3-5 [PMID: 355718 DOI: 10.1136/ gut.28.2.160]
56. Whitehead WE, Palsson OS, Levy RR, Feld AD, Turner M, Von Korff M. Comorbidity in irritable bowel syndrome. Am J Gastroenterol 2007; 102: 2767-2776 [PMID: 17900326 DOI: 10.1111/j.1572-0241.2007.01540.x]
57. Lee S, Wu J, Ma YL, Tsang A, Guo WJ, Sung J. Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study. Aliment Pharmacol Ther 2009; 30: 643-651 [PMID: 19552631 DOI: 10.1111/ j.1365-2036.2009.04074.x]
58. Pierrefiche G, Zerbib R, Laborit H. Anxiolytic activity of melatonin in mice: involvement of benzodiazepine receptors. Res Commun Chem Pathol Pharmacol 1993; 82: 131-142 [PMID: 7905658]
59. Kopp C, Vogel E, Rettori MC, Delagrange P, Misslin R. The effects of melatonin on the behavioural disturbances induced by chronic mild stress in C3H/He mice. Behav Pharmacol 1999; 10: 73-83 [PMID: 10780304 DOI: 10.1097/00008877-1999 02000-00007]
60. Brown GM. Day-night rhythm disturbance, pineal function and human disease. Horm Res 1992; 37 Suppl 3: 105-111 [PMID: 1427635 DOI: 10.1159/000182410]
61. Bellipanni G, Bianchi P, Pierpaoli W, Bulian D, Ilyia E. Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study. Exp Gerontol 2001; 36: 297-310 [PMID: 11226744 DOI: 10.1016/ S0531-5565(00)00217-5]
62. Brown GM. Neuroendocrine probes as biological markers of affective disorders: new directions. Can J Psychiatry 1989; 34: 819-823 [PMID: 2684381]
63. Song GH, Leng PH, Gwee KA, Moochhala SM, Ho KY. Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study. Gut 2005; 54: 1402-1407 [PMID: 15914575 DOI: 10.1136/gut.2004.062034]
64. Lakin ML, Miller CH, Stott ML, Winters WD. Involvement of the pineal gland and melatonin in murine analgesia. Life Sci 1981; 29: 2543-2551 [PMID: 7321776 DOI: 10.1016/0024-32 05(81)90710-4]
65. John TM, Brown MC, Wideman L, Brown GM. Melatonin replacement nullifies the effect of light-induced functional pinealectomy on nociceptive rhythm in the rat. Physiol Behav 1994; 55: 735-739 [PMID: 8190803 DOI: 10.1016/0031-9384(94)90053-1]
66. Kumar MS, Chen CL, Sharp DC, Liu JM, Kalra PS, Kalra SP. Diurnal fluctuations in methionine-enkephalin levels in the hypothalamus and preoptic area of the male rat: effects of pinealectomy. Neuroendocrinology 1982; 35: 28-31 [PMID: 7202129 DOI: 10.1159/000123350]
67. Ebadi M, Govitrapong P, Phansuwan-Pujito P, Nelson F, Reiter RJ. Pineal opioid receptors and analgesic action of melatonin. J Pineal Res 1998; 24: 193-200 [PMID: 9572527 DOI: 10.1111/j.1600-079X.1998.tb00532.x]
68. Shavali S, Ho B, Govitrapong P, Sawlom S, Ajjimaporn A, Klongpanichapak S, Ebadi M. Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of beta-endorphin an endogenous opioid. Brain Res Bull 2005; 64: 471-479 [PMID: 15639542 DOI: 10.1016/j.brainresbull.2004.09.008]
69. Ray M, Mediratta PK, Mahajan P, Sharma KK. Evaluation of the role of melatonin in formalin-induced pain response in mice. Indian J Med Sci 2004; 58: 122-130 [PMID: 15051907]
70. Peres MF, Rozen TD. Melatonin in the preventive treatment of chronic cluster headache. Cephalalgia 2001; 21: 993-995 [PMID: 11843873 DOI: 10.1046/j.1468-2982.2001.00307.x]
71. Peres MF, Zukerman E, da Cunha Tanuri F, Moreira FR, Cipolla-Neto J. Melatonin, 3 mg, is effective for migraine prevention. Neurology 2004; 63: 757 [PMID: 15326268 DOI: 10.1212/01.WNL.000013453.35587.24]
72. Chojnacki C, Walecka-Kapica E, Lokieć K, Pawłowicz M, Winczyk K, Chojnacki J, Klupińska G. Influence of melatonin on symptoms of irritable bowel syndrome in postmenopausal women. Endokrynol Pol 2013; 64: 114-120 [PMID: 23653274]
73. Lu WZ, Song GH, Gwee KA, Ho KY. The effects of melatonin on colonic transit time in normal controls and IBS patients. Dig Dis Sci 2009; 54: 1087-1093 [PMID: 18720001 DOI: 10.1007/s10620-008-0463-z]